Literature DB >> 9009123

Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis.

B F Werdmuller1, R J Loffeld.   

Abstract

In a prospective study of consecutive patients with reflux esophagitis and/or hiatal hernia and Barrett's esophagus, the prevalence of Helicobacter pylori was assessed. Antral biopsy specimens were studied and a serum sample for detection of IgG antibodies against Helicobacter pylori was taken. As a reference group patients presenting with a normal esophagus, stomach, and duodenum were taken. Reflux esophagitis was diagnosed in 118 patients, hiatal hernia without esophageal inflammation in 109, and Barrett's esophagus in 13. Helicobacter pylori was present in 74 (30%) of these patients and in 204 (51%) of the reference group. Prevalence of Helicobacter pylori was significantly lower in all groups compared with the reference group (P < 0.001). There was no difference when patients with esophagitis, Barrett's esophagus, or hiatal hernia were compared. Patients with esophagitis and Helicobacter pylori in their antrum are significantly older than esophagitis patients without concomitant Helicobacter infection, 61.5 (SD, 17) versus 53 (SD, 17) years (P < 0.001). It is concluded that the prevalence of Helicobacter pylori infection in patients with gastroesophageal reflux disease is significantly lower than in the reference group, irrespective of the severity of esophagitis. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009123     DOI: 10.1023/a:1018841222856

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Campylobacter pylori and duodenal ulcers: the gastrin link.

Authors:  S Levi; K Beardshall; G Haddad; R Playford; P Ghosh; J Calam
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

2.  Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.

Authors:  E el-Omar; I Penman; C A Dorrian; J E Ardill; K E McColl
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

3.  Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications.

Authors:  C Rosioru; M S Glassman; M S Halata; S M Schwarz
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

4.  Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.

Authors:  S F Moss; J Calam
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

5.  Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer.

Authors:  S Wagner; U Gladziwa; K Haruma; M Varrentrapp; M Gebel
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

6.  Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection.

Authors:  A S Peña; H P Endtz; G J Offerhaus; A Hoogenboom-Verdegaal; W van Duijn; N de Vargas; G den Hartog; J Kreuning; J van der Reyden; R P Mouton
Journal:  Digestion       Date:  1989       Impact factor: 3.216

7.  Long-term sequelae of Helicobacter pylori gastritis.

Authors:  E J Kuipers; A M Uyterlinde; A S Peña; R Roosendaal; G Pals; G F Nelis; H P Festen; S G Meuwissen
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

8.  Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus.

Authors:  R J Loffeld; B J Ten Tije; J W Arends
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

  8 in total
  38 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

3.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 4.  Helicobacter pylori and gastric diseases.

Authors:  M J Blaser
Journal:  BMJ       Date:  1998-05-16

Review 5.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

6.  RELATIONSHIP BETWEEN THE PRESENCE OF HELICOBACTER PYLORI WITH INFLAMMATORY ENDOSCOPIC CHANGES IN GASTRODUODENAL MUCOSA.

Authors:  Irma Cláudia Saboya Ribeiro; Luiz Fernandao Kubrusly; Paulo Afonso Nunes Nassif; Patrícia Fernanda Saboya Ribeiro; Rodrigo de Oliveira Veras; Aline Neppel
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

Review 7.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

8.  Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.

Authors:  Dulciene Maria Magalhães Queiroz; Gifone Aguiar Rocha; Celso Affonso de Oliveira; Andreia Maria Camargos Rocha; Adriana Santos; Mônica Maria Demas Alvares Cabral; Ana Margarida Miguel Ferreira Nogueira
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  H. pylori and reflux esophagitis in Turkish patients living in the Zaanstreek region in the Netherlands.

Authors:  R J L F Loffeld
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 10.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.